1.
Clin Infect Dis
; 75(1): e357-e360, 2022 08 24.
Article
in English
| MEDLINE | ID: covidwho-1713626
ABSTRACT
A key aim of serosurveillance during the coronavirus disease 2019 (COVID-19) pandemic has been to estimate the prevalence of prior infection, by correcting crude seroprevalence against estimated test performance for polymerase chain reaction (PCR)-confirmed COVID-19. We show that poor generalizability of sensitivity estimates to some target populations may lead to substantial underestimation of case numbers.